C08L89/00

Preparation method of green, biodegradable, and multifunctional collagen-based nanocomposite film

Disclosed a preparation method of a green, biodegradable, and multifunctional collagen-based nanocomposite film, and overcomes the problems of difficult biodegradation, poor barrier property, and single function of food packaging materials in the existing technologies. The present invention includes the following steps: adding silicate nanosheet into deionized water for ultrasonic dispersion; then adding polyphenolic acid into the mixture, wherein a mass ratio of the polyphenolic acid to the silicate nanosheet is 1:(0.2˜1); and adjusting the pH value to 3.0˜4.0 to obtain a solution A; adding collagen with a concentration of 5 g/L into an acetic acid solution, and fully dissolving the collagen to obtain a solution B; isovolumetrically mixing the solution A with the solution B, stirring at room temperature, and adjusting the pH value to 4.5˜5.5 to obtain a casting solution; and pouring the casting solution into a polytetrafluoroethylene mold, and naturally drying to obtain a nanocomposite film.

NATURAL COMPOSITION BASED ON POLYMERS TO BE ELECTROSPUN, AND METHOD TO PREPARE THE SAME

The invention concerns a composition to be electrospun comprising a first compound to be electrospun, an electrospinning promoter and at least one active ingredient, as well as a method to prepare it. This composition allows to obtain electrospun nanometric fibers with good structural and absorption properties.

NATURAL COMPOSITION BASED ON POLYMERS TO BE ELECTROSPUN, AND METHOD TO PREPARE THE SAME

The invention concerns a composition to be electrospun comprising a first compound to be electrospun, an electrospinning promoter and at least one active ingredient, as well as a method to prepare it. This composition allows to obtain electrospun nanometric fibers with good structural and absorption properties.

METHOD OF PREPARING POLYMER-FILLED CHROMATOGRAPHY RESIN

Methods of preparing polymer-filled chromatography resin and their uses are provided.

SCAFFOLDS TO TREAT SOLID TUMOR CELLS AND ESCAPE VARIANTS
20220339195 · 2022-10-27 ·

Implantable scaffolds that treat solid tumors and escape variants and that provide effective vaccinations against cancer recurrence are described. The scaffolds include genetically-reprogrammed lymphocytes and a lymphocyte-activating moiety.

SCAFFOLDS TO TREAT SOLID TUMOR CELLS AND ESCAPE VARIANTS
20220339195 · 2022-10-27 ·

Implantable scaffolds that treat solid tumors and escape variants and that provide effective vaccinations against cancer recurrence are described. The scaffolds include genetically-reprogrammed lymphocytes and a lymphocyte-activating moiety.

Biocompatible phase invertible proteinaceous compositions and methods for making and using the same
11478569 · 2022-10-25 · ·

Biocompatible phase invertible proteinaceous compositions and methods for making and using the same are provided. The subject phase invertible compositions are prepared by combining a crosslinker and a proteinaceous substrate. The proteinaceous substrate includes one or more proteins and a polyamine, where the polyamine and a proteinaceous substrate are present in synergistic viscosity enhancing amounts, and may also include one or more of: a carbohydrate, a tackifying agent, a plasticizer, or other modification agent. In certain embodiments, the crosslinker is a heat-treated dialdehyde, e.g., heat-treated glutaraldehyde. Also provided are kits for use in preparing the subject compositions. The subject compositions, kits and systems find use in a variety of different applications.

Biocompatible phase invertible proteinaceous compositions and methods for making and using the same
11478569 · 2022-10-25 · ·

Biocompatible phase invertible proteinaceous compositions and methods for making and using the same are provided. The subject phase invertible compositions are prepared by combining a crosslinker and a proteinaceous substrate. The proteinaceous substrate includes one or more proteins and a polyamine, where the polyamine and a proteinaceous substrate are present in synergistic viscosity enhancing amounts, and may also include one or more of: a carbohydrate, a tackifying agent, a plasticizer, or other modification agent. In certain embodiments, the crosslinker is a heat-treated dialdehyde, e.g., heat-treated glutaraldehyde. Also provided are kits for use in preparing the subject compositions. The subject compositions, kits and systems find use in a variety of different applications.

Biocompatible phase invertible proteinaceous compositions and methods for making and using the same
11478569 · 2022-10-25 · ·

Biocompatible phase invertible proteinaceous compositions and methods for making and using the same are provided. The subject phase invertible compositions are prepared by combining a crosslinker and a proteinaceous substrate. The proteinaceous substrate includes one or more proteins and a polyamine, where the polyamine and a proteinaceous substrate are present in synergistic viscosity enhancing amounts, and may also include one or more of: a carbohydrate, a tackifying agent, a plasticizer, or other modification agent. In certain embodiments, the crosslinker is a heat-treated dialdehyde, e.g., heat-treated glutaraldehyde. Also provided are kits for use in preparing the subject compositions. The subject compositions, kits and systems find use in a variety of different applications.

Opaque high-impact methyl methacrylate-butadiene-styrene polymer for improving impact resistance of polyvinyl chloride and preparation method thereof

An opaque high-impact methyl methacrylate-butadiene-styrene polymer (MBS) for improving impact resistance of polyvinyl chloride (PVC) including the following components by mass: 80-95% of core layer, 4-20% of shell layer and 0.001-0.05% of protective colloid, where the core layer is a butadiene (B) and styrene (S) polymer, the shell layer is one or a copolymer of two or three of S, acrylate and methyl methacrylate (MMA), and the protective colloid includes one or a compound of two or three of polyvinyl alcohol (PVA), gelatin and hydroxypropylmethyl cellulose (HPMC), may solve the problems of low impact resistance in the existing MBS product and difficult coagulation or spraying in the post-treatment process.